Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus

SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX

Dafna D. Gladman, Dominique Ibañez, Murray B. Urowitz · Elsevier eBooks · 2007 · 3K citations

Rheumatology, Clinical Finding, Autoimmune Disease +6

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

Lynda Bennett, Karolina Palucka, Edsel Arce et al. · The Journal of Experimental Medicine · 2003 · 1.9K citations · Full text

Vasculitis, Immunology, Pathology +18

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Richard Furie, Michelle Petri, Omid Zamani et al. · Arthritis & Rheumatism · 2011 · 1.6K citations · Full text

Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus

Richard Furie, Munther A. Khamashta, Joan T. Merrill et al. · Arthritis & Rheumatology · 2016 · 829 citations · Full text

Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

Romain Banchereau, Seunghee Hong, Brandi L. Cantarel et al. · Cell · 2016 · 707 citations · Full text